| Recent advances in neuroblastoma JM Maris New England Journal of Medicine 362 (23), 2202-2211, 2010 | 2153 | 2010 |
| Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ... New England Journal of Medicine 363 (14), 1324-1334, 2010 | 1916 | 2010 |
| Identification of ALK as a major familial neuroblastoma predisposition gene YP Mossé, M Laudenslager, L Longo, KA Cole, A Wood, EF Attiyeh, ... Nature 455 (7215), 930-935, 2008 | 1661 | 2008 |
| Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia WJ Song, MG Sullivan, RD Legare, S Hutchings, X Tan, D Kufrin, ... Nature genetics 23 (2), 166-175, 1999 | 1257 | 1999 |
| Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ... Cancer discovery 5 (12), 1282-1295, 2015 | 1214 | 2015 |
| The genetic landscape of high-risk neuroblastoma TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ... Nature genetics 45 (3), 279-284, 2013 | 1199 | 2013 |
| Molecular biology of neuroblastoma JM Maris, KK Matthay Journal of clinical oncology 17 (7), 2264-2264, 1999 | 811 | 1999 |
| Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study YP Mossé, MS Lim, SD Voss, K Wilner, K Ruffner, J Laliberte, D Rolland, ... The lancet oncology 14 (6), 472-480, 2013 | 790 | 2013 |
| Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours X Ma, YU Liu, Y Liu, LB Alexandrov, MN Edmonson, C Gawad, X Zhou, ... Nature 555 (7696), 371-376, 2018 | 746 | 2018 |
| Chromosome 1p and 11q deletions and outcome in neuroblastoma EF Attiyeh, WB London, YP Mossé, Q Wang, C Winter, D Khazi, ... New England Journal of Medicine 353 (21), 2243-2253, 2005 | 738 | 2005 |
| Comprehensive analysis of hypermutation in human cancer BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ... Cell 171 (5), 1042-1056. e10, 2017 | 710 | 2017 |
| Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group WB London, RP Castleberry, KK Matthay, AT Look, RC Seeger, ... Journal of clinical oncology 23 (27), 6459-6465, 2005 | 686 | 2005 |
| Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1 KE Nichols, JD Crispino, M Poncz, JG White, SH Orkin, JM Maris, ... Nature genetics 24 (3), 266-270, 2000 | 618 | 2000 |
| Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia M Bentires-Alj, JG Paez, FS David, H Keilhack, B Halmos, K Naoki, ... Cancer research 64 (24), 8816-8820, 2004 | 615 | 2004 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 556 | 2015 |
| The pediatric preclinical testing program: description of models and early testing results PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ... Pediatric blood & cancer 49 (7), 928-940, 2007 | 503 | 2007 |
| Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ... JAMA oncology 3 (5), 636-651, 2017 | 495 | 2017 |
| Chemoreduction in the initial management of intraocular retinoblastoma CL Shields, P De Potter, BP Himelstein, JA Shields, AT Meadows, ... Archives of ophthalmology 114 (11), 1330-1338, 1996 | 471 | 1996 |
| Malignant pheochromocytoma: current status and initiatives for future progress G Eisenhofer, SR Bornstein, FM Brouwers, NKV Cheung, PL Dahia, ... Endocrine-related cancer 11 (3), 423-436, 2004 | 469 | 2004 |
| Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. B Chance, JS Leigh Jr, BJ Clark, J Maris, J Kent, S Nioka, D Smith Proceedings of the National Academy of Sciences 82 (24), 8384-8388, 1985 | 466 | 1985 |
C Patrick ReynoldsCancer Center Director, TTUHSC School of Medicine在 ttuhsc.edu 的电子邮件经过验证
